4- (4-Aminophenoxy) -N-Methylpicolinamide CAS 284462-37-9 Sorafenib Tosylate Intermediate Factory High Purity
Nbubata Azụmahịa Sorafenib Tosylate na ihe ndị metụtara ya:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4- (4-Aminophenoxy) -N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3- (Trifluoromethyl) phenyl Isocyanate CAS: 327-78-6
| Aha Chemical | 4- (4-Aminophenoxy) -N-Methylpicolinamide |
| Ụdị okwu | 4- (4-Aminophenoxy) -N-Methyl-2-Pyridinecarboxamide |
| Nọmba CAS | 284462-37-9 |
| Nọmba CAT | RF-PI166 |
| Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
| Usoro ihe omimi | C13H13N3O2 |
| Ibu molekụla | 243.27 |
| Ebe Na-agbaze | 110.0 ~ 112.0 ℃ |
| Njupụta | 1.241 g/cm3 |
| Ụdị | Ruifu Chemical |
| Ihe | Nkọwapụta |
| Ọdịdị | Agba aja aja ka ọ bụrụ ntụ ntụ ọcha |
| Ụzọ ịdị ọcha / nyocha | 98.0% ~ 101.0% (na nke a mịrị amị) (HPLC) |
| Ọnwụ na ihicha | ≤0.50% |
| Ihe fọdụrụ na mgbanye | ≤0.20% |
| Otu adịghị ọcha | ≤0.20% |
| Mgbakọta adịghị ọcha | ≤1.0% |
| Ọla dị arọ | ≤20ppm |
| Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
| Ojiji | Ọkara nke Sorafenib Tosylate (CAS: 475207-59-1) |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe pụọ na ọkụ, mmiri mmiri na ọrịa nje.
Onye nrụpụta nwere ịdị ọcha dị elu yana ịdị mma kwụsie ike
Nbunye azụmaahịa Sorafenib Tosylate (CAS: 475207-59-1) Ndị na-emekọrịta ihe:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4- (4-Aminophenoxy) -N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3- (Trifluoromethyl) phenyl Isocyanate CAS: 327-78-6
Sorafenib Tosylate (CAS: 475207-59-1) bụ ụdị ọhụrụ ọgwụ antitumor nwere ọtụtụ ebumnuche, nke German Bayer Pharmaceuticals mepụtara, ma gosipụta ọrụ antitumor na-agbasawanye n'ule anụmanụ ndị na-aga n'ihu.Sorafenib dị na mbadamba 200-mg maka nchịkwa ọnụ ma ejiri ya na ọgwụgwọ RCC na HCC.
